This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)

3. Chelsea Therapeutics (CHTP) ^NBI Chart ^NBI data by YCharts

Chelsea shares started the year at well under $1, so it's spot among the best-performing biotech stocks is a bit misleading. Consider Chelsea's market is still only $170 million and that the stock price is down 50 percent from its level 18 months ago.

But give Chelsea credit for perseverance. Despite a roller coaster development path, the company is poised to resubmit Northera to FDA later this summer as a treatment for neurogenic orthostatic hypotension.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
CLVS $80.49 -1.80%
CLSN $2.55 -3.40%
KERX $10.11 -3.50%
MNKD $4.28 -2.10%
CHTP $0.00 0.00%


DOW 18,006.47 -63.93 -0.35%
S&P 500 2,101.24 -13.25 -0.63%
NASDAQ 4,959.8320 -57.0970 -1.14%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs